Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 15

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 15
---
 Securities sell or transfer some of their securities to the PIPE investors. Because the Founder Shares were acquired at a nominal price, our Public Shareholders will incur an immediate and substantial dilution upon the closing of this offering and will incur additional dilution upon the exercise of warrants held by the Sponsor and its affiliates. For more information about the potential conflicts of interest, the nature of compensation and the potential dilutive impact of such interests held by the Sponsor, Finnovate’s directors and officers and their respective affiliates, see the following sections in the accompanying proxy statement / prospectus: • “Questions and Answers about the Business Combination and the Extraordinary General Meeting- . What equity stake will current Finnovate Public Shareholders, the Sponsor and the Scage International shareholders and their affiliates hold in PubCo immediately after the completion of the Business Combination?” • “Risk Factors—Risks Related to the Business Combination and Finnovate—The Sponsor Parties paid nominal consideration for the Founder Shares they hold. As a result, the Sponsor Parties may make a substantial profit if the Business Combination is consummated, even if the shares held by Finnovate’s Public Shareholders lose substantial value. For this reason, the Sponsor Parties may have a strong economic incentive to approve and complete the Business Combination, even if the Business Combination arguably may not be in the best interests of Finnovate’s Public Shareholders” • “The Business Combination Proposal—Interests of Finnovate’s Directors and Officers in the Business Combination”; and • “Management of Finnovate—Executive Officer and Director Compensation.” Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued in the Business Combination or otherwise, or passed upon the adequacy or accuracy of this proxy statement / prospectus. Any representation to the contrary is a criminal offense. This proxy statement/prospectus is dated January6, 2025, and is first being mailed to Finnovate’s shareholders on or about January10, 2025. FINNOVATE ACQUISITION CORP. 265 Franklin Street
Suite 1702
Boston, MA 02110
+1 424-253-0908 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON JANUARY 30 , 2025 TO THE SHAREHOLDERS OF FINNOVATE: NOTICE IS HEREBY GIVEN that an extraordinary general meeting of shareholders (the “Meeting”) of Finnovate Acquisition Corp., a Cayman Islands